After completion of this module, you should be able to:
- Recognize the different causes of eczema including the differential diagnosis of AD
- Describe the different forms of treatment for AD
- Identify the side effects of topical corticosteroids
- Discuss the adverse effects of oral immunosuppressive agent including oral corticosteroids, used in atopic dermatitis
Faculty & Disclosures
Luz Fonacier, MD, FACAAI: Genentech- Research Grant; Merck- Research Grant; Baxter- Research Grant, Speaker; Church and Dwight, Co., Inc- Consultant
Mark Boguniewicz, MD, FACAAI: Anacor – Research Grant, Celgene, Regeneron – Advisory Board
Peter Lio: Anacor- Advisory Board; DermTap, Inc.-Advisory Board, Stock Options; Exeltis- Consultant; Ferndale Laboratories- Speaker; Galderma Laboratories, L.P.- Speaker, Consultant; IntraDerm Pharmaceuticals- Advisory Board;Johnson & Johnson- consultant, speaker, Advisory Board, Research Grant
Peck Ong, MD, FACAAI: Atopic dermatitis Research Network- Research Grant; Tioga – Research Grant; Regeneron – Advisory Board.
Gerald B. Lee, MD: Nothing to Disclose
The American College of Allergy, Asthma & Immunology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.